open access

Vol 5, Supp. A (2009)
suplement
Published online: 2009-04-29
Get Citation

Rationales for combining antiangiogenic treatment and radiotherapy

Ewa Sierko, Marek Z. Wojtukiewicz

open access

Vol 5, Supp. A (2009)
suplement
Published online: 2009-04-29

Abstract

Antiangiogenic treatment is among the most intensively studied fields in oncology. To date, cytotoxic chemotherapy in combination with therapy based on interfering with new vessel formation within the tumor was documented to improve survival in a subset of cancer patients.
Over 50% patients suffering from cancer undergo radiation therapy. In patients receiving definite radiotherapy radioresistance is a great obstacle, since it prevents loco-regional tumor control. In experimental studies the combination of radiation therapy with agents which are directed to proliferating and migrating endothelial cells results in an increased radiosensitivity of the cells to ionizing radiation. Furthermore, paradoxically, antiangiogenic therapy administration may lead to improved oxygenation of cancer cells, which directly contributes to increased cancer radiosensitivity and improved treatment results of cancer patients. However, it should be emphasized that combination of antiangiogenic treatment with radiation therapy may increase the risk of radiation sequels.Pathophisiological rationales for combining of the two mentioned above methods in the therapy of cancer patients as well for introducing such treatment strategy into clinical trials were discussed.

Abstract

Antiangiogenic treatment is among the most intensively studied fields in oncology. To date, cytotoxic chemotherapy in combination with therapy based on interfering with new vessel formation within the tumor was documented to improve survival in a subset of cancer patients.
Over 50% patients suffering from cancer undergo radiation therapy. In patients receiving definite radiotherapy radioresistance is a great obstacle, since it prevents loco-regional tumor control. In experimental studies the combination of radiation therapy with agents which are directed to proliferating and migrating endothelial cells results in an increased radiosensitivity of the cells to ionizing radiation. Furthermore, paradoxically, antiangiogenic therapy administration may lead to improved oxygenation of cancer cells, which directly contributes to increased cancer radiosensitivity and improved treatment results of cancer patients. However, it should be emphasized that combination of antiangiogenic treatment with radiation therapy may increase the risk of radiation sequels.Pathophisiological rationales for combining of the two mentioned above methods in the therapy of cancer patients as well for introducing such treatment strategy into clinical trials were discussed.
Get Citation

Keywords

antiangiogenic agents; radiation therapy; angiogenesis; hypoxia; VEGF; radiation complications

About this article
Title

Rationales for combining antiangiogenic treatment and radiotherapy

Journal

Oncology in Clinical Practice

Issue

Vol 5, Supp. A (2009)

Pages

62-68

Published online

2009-04-29

Keywords

antiangiogenic agents
radiation therapy
angiogenesis
hypoxia
VEGF
radiation complications

Authors

Ewa Sierko
Marek Z. Wojtukiewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl